Recent GLP-1 (glucagon-like peptide-1) obesity treatments such as ‘Wegovy’ and ‘Mounjaro’ have gained immense popularity, but ...
Learn how new oral GLP-1 weight loss pills work, how they compare with injections, and how the next generation of “small ...
Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that it has selected ASC37 injection, a next-generation, once-monthly, subcutaneously administered GLP-1R/GIPR/GCGR[1] triple peptide agonist, ...
Following the hard-won success of early anti-amyloid drugs, a new generation of Alzheimer’s modalities—from tau-targeting ...
The FDA has cleared a mobile application that will connect with a next-generation multiple daily injection automated insulin ...